GlassScriptPhysician profile
Michael Joseph Jacobs
NPI 1619123726
$1,207.56
in general payments reported to CMS, 2019-2025
10 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $193 · 2023: $293 · 2024: $243 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $462.80 | 2021-2025 | Nucala, Trelegy Ellipta |
| Abbott Laboratories | $267.35 | 2023-2024 | Freestyle Libre 3 |
| Amgen INC. | $135.91 | 2021-2025 | Evenity |
| Alcon Vision LLC | $134.42 | 2022 | |
| Abbvie INC. | $94.83 | 2021-2025 | |
| Becton, Dickinson and Company | $30.00 | 2021 | |
| Hologic Sales and Service, LLC | $26.14 | 2021 | |
| Ascensia Diabetes Care US INC. | $24.30 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.